The patent describes a method for detecting protein-protein interactions in living cells and animals. Protein interactions define the intricate biochemical networks in living cells, and are used at Odyssey Thera to monitor drug response. The invention is said to help monitor specific biochemical parameters, including the extent and kinetics of drug target modulation, in a live subject.
John Westwick, CEO of Odyssey Thera and co-author on the patent, said: “This patent extends our broad estate in drug discovery technologies. With this invention, drug discovery and development are achieved with a single system that faithfully monitors the activity of a drug at each step.”